This live session provides a focused, case-based review of cannabis use disorder and related conditions, emphasizing assessment, diagnosis, and management across a range of clinical settings.
What This Includes
• Epidemiology, patterns of use, and risk factors for cannabis use and cannabis-related disorders• Pharmacology of cannabis and core concepts related to the endocannabinoid system• Recognition and management of cannabis intoxication and withdrawal• Associated clinical syndromes, including anxiety, psychosis, and sleep disturbances• Screening strategies and diagnostic criteria for cannabis use disorder• Current treatment approaches, including psychotherapy and emerging pharmacologic options• Considerations related to evolving cannabis products, unregulated cannabinoids, and clinical decision-making
What to Expect
• Live, faculty-led instruction delivered in an interactive online format• Case-based discussion highlighting real-world clinical presentation and management challenges• Structured content aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas• Emphasis on high-yield concepts for board review and clinical application• Practical guidance for assessing and managing cannabis-related disorders across care settings
Greg S. Swartzentruber, MD
Dr. Swartzentruber is an addiction medicine physician at UPMC (Harrisburg), where he serves as Addiction Medicine Fellowship Director. He is board certified in Addiction Medicine, Medical Toxicology, and Emergency Medicine and practices at the UPMC Center for Addiction Medicine.
He completed his medical degree at Penn State College of Medicine, followed by residency training in emergency medicine and fellowship training at UPMC, and is actively involved in the clinical management of patients with substance use disorders.
Dr. Swartzentruber will be joined by a UPMC (Harrisburg) addiction medicine fellowship program fellow.
To support a meaningful learning experience and recognize your participation: